These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 9816273)

  • 41. Identification of genes that are regulated transcriptionally by Myc in childhood tumors.
    Raetz EA; Kim MK; Moos P; Carlson M; Bruggers C; Hooper DK; Foot L; Liu T; Seeger R; Carroll WL
    Cancer; 2003 Aug; 98(4):841-53. PubMed ID: 12910530
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Analysis of genomic imprinting at 1p35-36 in neuroblastoma.
    Hogarty MD; Maris JM; White PS; Guo C; Brodeur GM
    Med Pediatr Oncol; 2001 Jan; 36(1):52-5. PubMed ID: 11464906
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Deleted in colon cancer protein expression in colorectal cancer metastases: a major predictor of survival in patients with unresectable metastatic disease receiving palliative fluorouracil-based chemotherapy.
    Aschele C; Debernardis D; Lonardi S; Bandelloni R; Casazza S; Monfardini S; Gallo L
    J Clin Oncol; 2004 Sep; 22(18):3758-65. PubMed ID: 15365072
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Persistent expression of the tumor suppressor gene DCC is essential for neuronal differentiation.
    Lawlor KG; Narayanan R
    Cell Growth Differ; 1992 Sep; 3(9):609-16. PubMed ID: 1419911
    [TBL] [Abstract][Full Text] [Related]  

  • 45. N-myc regulation of type I insulin-like growth factor receptor in a human neuroblastoma cell line.
    Chambéry D; Mohseni-Zadeh S; de Gallé B; Babajko S
    Cancer Res; 1999 Jun; 59(12):2898-902. PubMed ID: 10383152
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The basic helix-loop-helix transcription factor dHAND, a marker gene for the developing human sympathetic nervous system, is expressed in both high- and low-stage neuroblastomas.
    Gestblom C; Grynfeld A; Ora I; Ortoft E; Larsson C; Axelson H; Sandstedt B; Cserjesi P; Olson EN; Påhlman S
    Lab Invest; 1999 Jan; 79(1):67-79. PubMed ID: 9952112
    [TBL] [Abstract][Full Text] [Related]  

  • 47. p53 and DCC immunohistochemistry in curative rectal cancer surgery.
    Morgan M; Koorey D; Painter D; Findlay M; Newland R; Chapuis P; Solomon M
    Int J Colorectal Dis; 2003 May; 18(3):188-95. PubMed ID: 12673482
    [TBL] [Abstract][Full Text] [Related]  

  • 48. DCC expression is altered by multiple mechanisms in brain tumours.
    Ekstrand BC; Mansfield TA; Bigner SH; Fearon ER
    Oncogene; 1995 Dec; 11(11):2393-402. PubMed ID: 8570191
    [TBL] [Abstract][Full Text] [Related]  

  • 49. S-cells from a highly N-myc-amplified neuroblastoma are tumorigenic in nude mice.
    Sleight BJ; Soukup S; Ballard ET; Parysek LM
    Anticancer Res; 1993; 13(6A):2031-6. PubMed ID: 8297111
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Frequent loss of expression without sequence mutations of the DCC gene in primary gastric cancer.
    Sato K; Tamura G; Tsuchiya T; Endoh Y; Usuba O; Kimura W; Motoyama T
    Br J Cancer; 2001 Jul; 85(2):199-203. PubMed ID: 11461076
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Decreased expression of the candidate tumor suppressor gene ING1 is associated with poor prognosis in advanced neuroblastomas.
    Takahashi M; Ozaki T; Todo S; Nakagawara A
    Oncol Rep; 2004 Oct; 12(4):811-6. PubMed ID: 15375504
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Oligonucleotide microarray analysis of gene expression in neuroblastoma displaying loss of chromosome 11q.
    McArdle L; McDermott M; Purcell R; Grehan D; O'Meara A; Breatnach F; Catchpoole D; Culhane AC; Jeffery I; Gallagher WM; Stallings RL
    Carcinogenesis; 2004 Sep; 25(9):1599-609. PubMed ID: 15090470
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The DCC gene suppresses the malignant phenotype of transformed human epithelial cells.
    Klingelhutz AJ; Hedrick L; Cho KR; McDougall JK
    Oncogene; 1995 Apr; 10(8):1581-6. PubMed ID: 7731713
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The DCC gene product in cellular differentiation and colorectal tumorigenesis.
    Hedrick L; Cho KR; Fearon ER; Wu TC; Kinzler KW; Vogelstein B
    Genes Dev; 1994 May; 8(10):1174-83. PubMed ID: 7926722
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Frequent reduction or loss of DCC gene expression in human osteosarcoma.
    Horstmann MA; Pösl M; Scholz RB; Anderegg B; Simon P; Baumgaertl K; Delling G; Kabisch H
    Br J Cancer; 1997; 75(9):1309-17. PubMed ID: 9155051
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Alterations of the tumour suppressor gene DCC in neuroblastoma.
    Kong XT; Choi SH; Inoue A; Takita J; Yokota J; Hanada R; Yamamoto K; Bessho F; Yanagisawa M; Hayashi Y
    Eur J Cancer; 1997 Oct; 33(12):1962-5. PubMed ID: 9516833
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Studies of the deleted in colorectal cancer gene in normal and neoplastic tissues.
    Fearon ER; Ekstrand BC; Hu G; Pierceall WE; Reale MA; Bigner SH
    Cold Spring Harb Symp Quant Biol; 1994; 59():637-43. PubMed ID: 7587124
    [TBL] [Abstract][Full Text] [Related]  

  • 58. In vivo spontaneous neuronal to neuroendocrine lineage conversion in a subset of neuroblastomas.
    Gestblom C; Hoehner JC; Hedborg F; Sandstedt B; Påhlman S
    Am J Pathol; 1997 Jan; 150(1):107-17. PubMed ID: 9006328
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mutation and expression of the DCC gene in human lung cancer.
    Kohno T; Sato T; Takakura S; Takei K; Inoue K; Nishioka M; Yokota J
    Neoplasia; 2000; 2(4):300-5. PubMed ID: 11005564
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hsp27 expression in neuroblastoma: correlation with disease stage.
    Ungar DR; Hailat N; Strahler JR; Kuick RD; Brodeur GM; Seeger RC; Reynolds CP; Hanash SM
    J Natl Cancer Inst; 1994 May; 86(10):780-4. PubMed ID: 8169976
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.